Thromboxane receptor (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Thromboxane receptor" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

6semanticscholar.org

11^th place

8^th place

1,626^th place

1,007^th place

1guidetopharmacology.org

low place

low place

low place

low place

102^nd place

76^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Devillier P, Bessard G (1997). "Thromboxane A₂ and related prostaglandins in airways". Fundam Clin Pharmacol. 11 (1): 2–18. doi:10.1111/j.1472-8206.1997.tb00163.x. PMID 9182072. S2CID 20514470.
Rolin S, Masereel B, Dogné JM (March 2006). "Prostanoids as pharmacological targets in COPD and asthma". Eur J Pharmacol. 533 (1–3): 89–100. doi:10.1016/j.ejphar.2005.12.058. PMID 16458293.
Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K (1995). "Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization". J. Clin. Invest. 96 (2): 657–64. doi:10.1172/JCI118108. PMC 185246. PMID 7635958.
Huang JS, Ramamurthy SK, Lin X, Le Breton GC (May 2004). "Cell signalling through thromboxane A2 receptors". Cell Signal. 16 (5): 521–33. doi:10.1016/j.cellsig.2003.10.008. PMID 14751539.
Foulon I, Bachir D, Galacteros F, Maclouf J (1993). "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619". Arteriosclerosis and Thrombosis. 13 (3): 421–6. doi:10.1161/01.atv.13.3.421. PMID 8443146.
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2014). "Cyclooxygenase pathways". Acta Biochimica Polonica. 61 (4): 639–49. doi:10.18388/abp.2014_1825. PMID 25343148.
Ricciotti E, FitzGerald GA (2011). "Prostaglandins and inflammation". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (5): 986–1000. doi:10.1161/ATVBAHA.110.207449. PMC 3081099. PMID 21508345.
Woodward DF, Jones RL, Narumiya S (2011). "International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress". Pharmacological Reviews. 63 (3): 471–538. doi:10.1124/pr.110.003517. PMID 21752876.
Capra V, Bäck M, Angiolillo DJ, Cattaneo M, Sakariassen KS (2014). "Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation". Journal of Thrombosis and Haemostasis. 12 (2): 126–37. doi:10.1111/jth.12472. PMID 24298905. S2CID 26569858.
Bauer J, Ripperger A, Frantz S, Ergün S, Schwedhelm E, Benndorf RA (2014). "Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation". British Journal of Pharmacology. 171 (13): 3115–31. doi:10.1111/bph.12677. PMC 4080968. PMID 24646155.
Shen RF, Tai HH (1998). "Thromboxanes: synthase and receptors". J Biomed Sci. 5 (3): 153–72. doi:10.1007/BF02253465. PMID 9678486.
Hoxha M, Buccellati C, Capra V, Garella D, Cena C, Rolando B, Fruttero R, Carnevali S, Sala A, Rovati GE, Bertinaria M (2016). "In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition" (PDF). Pharmacological Research. 103: 132–43. doi:10.1016/j.phrs.2015.11.012. hdl:2318/1551575. PMID 26621246. S2CID 12881002.
Matsuoka T, Narumiya S (2008). "The roles of prostanoids in infection and sickness behaviors". Journal of Infection and Chemotherapy. 14 (4): 270–8. doi:10.1007/s10156-008-0622-3. PMID 18709530. S2CID 207058745.
Mhaouty-Kodja S (2004). "Ghalpha/tissue transglutaminase 2: an emerging G protein in signal transduction". Biology of the Cell. 96 (5): 363–7. doi:10.1016/j.biolcel.2004.03.003. PMID 15207905.
Park MK, Choi JK, Kim HJ, Nakahata N, Lim KM, Kim SY, Lee CH (2014). "Novel inhibitory effects of cardamonin on thromboxane A2-induced scratching response: Blocking of Gh/transglutaminase-2 binding to thromboxane A2 receptor". Pharmacology Biochemistry and Behavior. 126: 131–5. doi:10.1016/j.pbb.2014.09.011. PMID 25285619. S2CID 144250159.
Aggarwal S, Randhawa PK, Singh N, Jaggi AS (2016). "Preconditioning at a distance: Involvement of endothelial vasoactive substances in cardioprotection against ischemia-reperfusion injury". Life Sciences. 151: 250–8. doi:10.1016/j.lfs.2016.03.021. PMID 26979771.
Kroetz DL, Xu F (2005). "Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation". Annual Review of Pharmacology and Toxicology. 45: 413–38. doi:10.1146/annurev.pharmtox.45.120403.100045. PMID 15822183.
Toth P, Rozsa B, Springo Z, Doczi T, Koller A (2011). "Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP receptors". Journal of Cerebral Blood Flow and Metabolism. 31 (10): 2096–105. doi:10.1038/jcbfm.2011.74. PMC 3208155. PMID 21610722.
Claar D, Hartert TV, Peebles RS (2015). "The role of prostaglandins in allergic lung inflammation and asthma". Expert Review of Respiratory Medicine. 9 (1): 55–72. doi:10.1586/17476348.2015.992783. PMC 4380345. PMID 25541289.
Liu T, Garofalo D, Feng C, Lai J, Katz H, Laidlaw TM, Boyce JA (2015). "Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors". Journal of Immunology. 194 (11): 5061–8. doi:10.4049/jimmunol.1402959. PMC 4433852. PMID 25904552.
Nakahata N (2008). "Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology". Pharmacology & Therapeutics. 118 (1): 18–35. doi:10.1016/j.pharmthera.2008.01.001. PMID 18374420.
Sakata D, Yao C, Narumiya S (2010). "Emerging roles of prostanoids in T cell-mediated immunity". IUBMB Life. 62 (8): 591–6. doi:10.1002/iub.356. PMID 20665621. S2CID 9889648.
Ekambaram P, Lambiv W, Cazzolli R, Ashton AW, Honn KV (2011). "The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis". Cancer and Metastasis Reviews. 30 (3–4): 397–408. doi:10.1007/s10555-011-9297-9. PMC 4175445. PMID 22037941.
Nisar SP, Jones ML, Cunningham MR, Mumford AD, Mundell SJ (2015). "Rare platelet GPCR variants: what can we learn?". British Journal of Pharmacology. 172 (13): 3242–53. doi:10.1111/bph.12941. PMC 4500363. PMID 25231155.
Cornejo-García JA, Perkins JR, Jurado-Escobar R, García-Martín E, Agúndez JA, Viguera E, Pérez-Sánchez N, Blanca-López N (2016). "Pharmacogenomics of Prostaglandin and Leukotriene Receptors". Frontiers in Pharmacology. 7: 316. doi:10.3389/fphar.2016.00316. PMC 5030812. PMID 27708579.
Thompson MD, Capra V, Clunes MT, Rovati GE, Stankova J, Maj MC, Duffy DL (2016). "Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies". Frontiers in Pharmacology. 7: 299. doi:10.3389/fphar.2016.00299. PMC 5131607. PMID 27990118.

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000006638 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000034881 – Ensembl, May 2017

guidetopharmacology.org (Global: low place; English: low place)

"TP receptor | Prostanoid receptors | IUPHAR/BPS Guide to PHARMACOLOGY".

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Hoxha M, Buccellati C, Capra V, Garella D, Cena C, Rolando B, Fruttero R, Carnevali S, Sala A, Rovati GE, Bertinaria M (2016). "In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition" (PDF). Pharmacological Research. 103: 132–43. doi:10.1016/j.phrs.2015.11.012. hdl:2318/1551575. PMID 26621246. S2CID 12881002.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Devillier P, Bessard G (1997). "Thromboxane A₂ and related prostaglandins in airways". Fundam Clin Pharmacol. 11 (1): 2–18. doi:10.1111/j.1472-8206.1997.tb00163.x. PMID 9182072. S2CID 20514470.
Rolin S, Masereel B, Dogné JM (March 2006). "Prostanoids as pharmacological targets in COPD and asthma". Eur J Pharmacol. 533 (1–3): 89–100. doi:10.1016/j.ejphar.2005.12.058. PMID 16458293.
Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K (1995). "Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization". J. Clin. Invest. 96 (2): 657–64. doi:10.1172/JCI118108. PMC 185246. PMID 7635958.
Huang JS, Ramamurthy SK, Lin X, Le Breton GC (May 2004). "Cell signalling through thromboxane A2 receptors". Cell Signal. 16 (5): 521–33. doi:10.1016/j.cellsig.2003.10.008. PMID 14751539.
Foulon I, Bachir D, Galacteros F, Maclouf J (1993). "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619". Arteriosclerosis and Thrombosis. 13 (3): 421–6. doi:10.1161/01.atv.13.3.421. PMID 8443146.
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2014). "Cyclooxygenase pathways". Acta Biochimica Polonica. 61 (4): 639–49. doi:10.18388/abp.2014_1825. PMID 25343148.
Ricciotti E, FitzGerald GA (2011). "Prostaglandins and inflammation". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (5): 986–1000. doi:10.1161/ATVBAHA.110.207449. PMC 3081099. PMID 21508345.
Woodward DF, Jones RL, Narumiya S (2011). "International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress". Pharmacological Reviews. 63 (3): 471–538. doi:10.1124/pr.110.003517. PMID 21752876.
Capra V, Bäck M, Angiolillo DJ, Cattaneo M, Sakariassen KS (2014). "Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation". Journal of Thrombosis and Haemostasis. 12 (2): 126–37. doi:10.1111/jth.12472. PMID 24298905. S2CID 26569858.
Bauer J, Ripperger A, Frantz S, Ergün S, Schwedhelm E, Benndorf RA (2014). "Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation". British Journal of Pharmacology. 171 (13): 3115–31. doi:10.1111/bph.12677. PMC 4080968. PMID 24646155.
Shen RF, Tai HH (1998). "Thromboxanes: synthase and receptors". J Biomed Sci. 5 (3): 153–72. doi:10.1007/BF02253465. PMID 9678486.
Hoxha M, Buccellati C, Capra V, Garella D, Cena C, Rolando B, Fruttero R, Carnevali S, Sala A, Rovati GE, Bertinaria M (2016). "In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition" (PDF). Pharmacological Research. 103: 132–43. doi:10.1016/j.phrs.2015.11.012. hdl:2318/1551575. PMID 26621246. S2CID 12881002.
Matsuoka T, Narumiya S (2008). "The roles of prostanoids in infection and sickness behaviors". Journal of Infection and Chemotherapy. 14 (4): 270–8. doi:10.1007/s10156-008-0622-3. PMID 18709530. S2CID 207058745.
Mhaouty-Kodja S (2004). "Ghalpha/tissue transglutaminase 2: an emerging G protein in signal transduction". Biology of the Cell. 96 (5): 363–7. doi:10.1016/j.biolcel.2004.03.003. PMID 15207905.
Park MK, Choi JK, Kim HJ, Nakahata N, Lim KM, Kim SY, Lee CH (2014). "Novel inhibitory effects of cardamonin on thromboxane A2-induced scratching response: Blocking of Gh/transglutaminase-2 binding to thromboxane A2 receptor". Pharmacology Biochemistry and Behavior. 126: 131–5. doi:10.1016/j.pbb.2014.09.011. PMID 25285619. S2CID 144250159.
Silva BR, Paula TD, Paulo M, Bendhack LM (2016). "Nitric oxide signaling and the cross talk with prostanoids pathways in vascular system". Medicinal Chemistry. PMID 28031017.
Aggarwal S, Randhawa PK, Singh N, Jaggi AS (2016). "Preconditioning at a distance: Involvement of endothelial vasoactive substances in cardioprotection against ischemia-reperfusion injury". Life Sciences. 151: 250–8. doi:10.1016/j.lfs.2016.03.021. PMID 26979771.
Kroetz DL, Xu F (2005). "Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation". Annual Review of Pharmacology and Toxicology. 45: 413–38. doi:10.1146/annurev.pharmtox.45.120403.100045. PMID 15822183.
Toth P, Rozsa B, Springo Z, Doczi T, Koller A (2011). "Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP receptors". Journal of Cerebral Blood Flow and Metabolism. 31 (10): 2096–105. doi:10.1038/jcbfm.2011.74. PMC 3208155. PMID 21610722.
Claar D, Hartert TV, Peebles RS (2015). "The role of prostaglandins in allergic lung inflammation and asthma". Expert Review of Respiratory Medicine. 9 (1): 55–72. doi:10.1586/17476348.2015.992783. PMC 4380345. PMID 25541289.
Liu T, Garofalo D, Feng C, Lai J, Katz H, Laidlaw TM, Boyce JA (2015). "Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors". Journal of Immunology. 194 (11): 5061–8. doi:10.4049/jimmunol.1402959. PMC 4433852. PMID 25904552.
Nakahata N (2008). "Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology". Pharmacology & Therapeutics. 118 (1): 18–35. doi:10.1016/j.pharmthera.2008.01.001. PMID 18374420.
Sakata D, Yao C, Narumiya S (2010). "Emerging roles of prostanoids in T cell-mediated immunity". IUBMB Life. 62 (8): 591–6. doi:10.1002/iub.356. PMID 20665621. S2CID 9889648.
Ekambaram P, Lambiv W, Cazzolli R, Ashton AW, Honn KV (2011). "The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis". Cancer and Metastasis Reviews. 30 (3–4): 397–408. doi:10.1007/s10555-011-9297-9. PMC 4175445. PMID 22037941.
Nisar SP, Jones ML, Cunningham MR, Mumford AD, Mundell SJ (2015). "Rare platelet GPCR variants: what can we learn?". British Journal of Pharmacology. 172 (13): 3242–53. doi:10.1111/bph.12941. PMC 4500363. PMID 25231155.
Cornejo-García JA, Perkins JR, Jurado-Escobar R, García-Martín E, Agúndez JA, Viguera E, Pérez-Sánchez N, Blanca-López N (2016). "Pharmacogenomics of Prostaglandin and Leukotriene Receptors". Frontiers in Pharmacology. 7: 316. doi:10.3389/fphar.2016.00316. PMC 5030812. PMID 27708579.
Thompson MD, Capra V, Clunes MT, Rovati GE, Stankova J, Maj MC, Duffy DL (2016). "Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies". Frontiers in Pharmacology. 7: 299. doi:10.3389/fphar.2016.00299. PMC 5131607. PMID 27990118.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"TBXA2R thromboxane A2 receptor [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2023-09-09.
Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K (1995). "Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization". J. Clin. Invest. 96 (2): 657–64. doi:10.1172/JCI118108. PMC 185246. PMID 7635958.
Ricciotti E, FitzGerald GA (2011). "Prostaglandins and inflammation". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (5): 986–1000. doi:10.1161/ATVBAHA.110.207449. PMC 3081099. PMID 21508345.
Bauer J, Ripperger A, Frantz S, Ergün S, Schwedhelm E, Benndorf RA (2014). "Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation". British Journal of Pharmacology. 171 (13): 3115–31. doi:10.1111/bph.12677. PMC 4080968. PMID 24646155.
Toth P, Rozsa B, Springo Z, Doczi T, Koller A (2011). "Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP receptors". Journal of Cerebral Blood Flow and Metabolism. 31 (10): 2096–105. doi:10.1038/jcbfm.2011.74. PMC 3208155. PMID 21610722.
Claar D, Hartert TV, Peebles RS (2015). "The role of prostaglandins in allergic lung inflammation and asthma". Expert Review of Respiratory Medicine. 9 (1): 55–72. doi:10.1586/17476348.2015.992783. PMC 4380345. PMID 25541289.
Liu T, Garofalo D, Feng C, Lai J, Katz H, Laidlaw TM, Boyce JA (2015). "Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors". Journal of Immunology. 194 (11): 5061–8. doi:10.4049/jimmunol.1402959. PMC 4433852. PMID 25904552.
Ekambaram P, Lambiv W, Cazzolli R, Ashton AW, Honn KV (2011). "The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis". Cancer and Metastasis Reviews. 30 (3–4): 397–408. doi:10.1007/s10555-011-9297-9. PMC 4175445. PMID 22037941.
Nisar SP, Jones ML, Cunningham MR, Mumford AD, Mundell SJ (2015). "Rare platelet GPCR variants: what can we learn?". British Journal of Pharmacology. 172 (13): 3242–53. doi:10.1111/bph.12941. PMC 4500363. PMID 25231155.
Cornejo-García JA, Perkins JR, Jurado-Escobar R, García-Martín E, Agúndez JA, Viguera E, Pérez-Sánchez N, Blanca-López N (2016). "Pharmacogenomics of Prostaglandin and Leukotriene Receptors". Frontiers in Pharmacology. 7: 316. doi:10.3389/fphar.2016.00316. PMC 5030812. PMID 27708579.
Thompson MD, Capra V, Clunes MT, Rovati GE, Stankova J, Maj MC, Duffy DL (2016). "Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies". Frontiers in Pharmacology. 7: 299. doi:10.3389/fphar.2016.00299. PMC 5131607. PMID 27990118.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Devillier P, Bessard G (1997). "Thromboxane A₂ and related prostaglandins in airways". Fundam Clin Pharmacol. 11 (1): 2–18. doi:10.1111/j.1472-8206.1997.tb00163.x. PMID 9182072. S2CID 20514470.
Capra V, Bäck M, Angiolillo DJ, Cattaneo M, Sakariassen KS (2014). "Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation". Journal of Thrombosis and Haemostasis. 12 (2): 126–37. doi:10.1111/jth.12472. PMID 24298905. S2CID 26569858.
Hoxha M, Buccellati C, Capra V, Garella D, Cena C, Rolando B, Fruttero R, Carnevali S, Sala A, Rovati GE, Bertinaria M (2016). "In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition" (PDF). Pharmacological Research. 103: 132–43. doi:10.1016/j.phrs.2015.11.012. hdl:2318/1551575. PMID 26621246. S2CID 12881002.
Matsuoka T, Narumiya S (2008). "The roles of prostanoids in infection and sickness behaviors". Journal of Infection and Chemotherapy. 14 (4): 270–8. doi:10.1007/s10156-008-0622-3. PMID 18709530. S2CID 207058745.
Park MK, Choi JK, Kim HJ, Nakahata N, Lim KM, Kim SY, Lee CH (2014). "Novel inhibitory effects of cardamonin on thromboxane A2-induced scratching response: Blocking of Gh/transglutaminase-2 binding to thromboxane A2 receptor". Pharmacology Biochemistry and Behavior. 126: 131–5. doi:10.1016/j.pbb.2014.09.011. PMID 25285619. S2CID 144250159.
Sakata D, Yao C, Narumiya S (2010). "Emerging roles of prostanoids in T cell-mediated immunity". IUBMB Life. 62 (8): 591–6. doi:10.1002/iub.356. PMID 20665621. S2CID 9889648.

unito.it (Global: low place; English: low place)

iris.unito.it

Hoxha M, Buccellati C, Capra V, Garella D, Cena C, Rolando B, Fruttero R, Carnevali S, Sala A, Rovati GE, Bertinaria M (2016). "In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition" (PDF). Pharmacological Research. 103: 132–43. doi:10.1016/j.phrs.2015.11.012. hdl:2318/1551575. PMID 26621246. S2CID 12881002.